Join the FDA’s Center for Biologics Evaluation and Research (CBER) Office of Tissues and Advanced Therapies (OTAT) for its upcoming #RegenMedEd
webinar on March 9 at 11 a.m. EST: The Critical Role of Patients in Advancing Gene Therapy Treatments for Rare Diseases. Register now: bit.ly/3425RA9
The webinar will bring together patients, caregivers, advocates, and other important stakeholders to celebrate and recognize the contributions that patients with rare diseases have made to advancements in regenerative medicine.
Please join this important conversation:
• Date: Wednesday, March 9, 2022
• Time: 11:00 a.m.–12:00 p.m. EST
• Location: This free virtual webinar will be hosted on Zoom.
• Registration: Registration is required.